Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.

S. Galal,Ahmed S. Abdelsamie,S. Shouman,Yasmin M Attia,Hamed I. Ali,A. Tabll,Reem El-Shenawy,Y. E. El Abd,Mamdouh M. Ali,Abeer E E Mahmoud,A. Abdel-Halim,A. Fyiad,A. S. Girgis,H. El-Diwani
DOI: https://doi.org/10.1016/j.ejmech.2017.03.090
IF: 7.088
2017-07-07
European Journal of Medicinal Chemistry
Abstract:
What problem does this paper attempt to address?